Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
R&D Expense Growth TrendStable
Percentile Rank14
Year-over-Year Change
Year-over-year research & development expense growth
Latest
0.00%
↑ 100% vs avg
Percentile
P14
Within normal range
Streak
1 yr
Consecutive growthStable
Average
-2.61%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 0.00% |
| 2024 | -100.00% |
| 2023 | 8.33% |
| 2022 | 9.09% |
| 2021 | -8.33% |
| 2020 | 16.49% |
| 2019 | 48.30% |
| 2018 | 0.00% |
| 2017 | 0.00% |
| 2016 | 0.00% |